Iron therapy and severe arrhythmias in HFrEF: rationale, study design, and baseline results of the RESAFE‐HF trial

Abstract Aims The Iron Intravenous Therapy in Reducing the burden of Severe Arrhythmias in HFrEF (RESAFE‐HF) registry study aims to provide real‐word evidence on the impact of intravenous ferric carboxymaltose (FCM) on the arrhythmic burden of patients with heart failure with reduced ejection fracti...

Descripción completa

Detalles Bibliográficos

Autores principales:	Constantinos Bakogiannis, Dimitrios Mouselimis, Anastasios Tsarouchas, Christodoulos E. Papadopoulos, Efstratios K. Theofillogiannakos, Elmira Lechat, Antonios P. Antoniadis, Efstathios D. Pagourelias, Ioannis Kelemanis, Stergios Tzikas, Nikolaos Fragakis, Georgios K. Efthimiadis, Theodoros D. Karamitsos, Michael Doumas, Vassilios P. Vassilikos
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Oxford University Press 2023-04-01
Colección:	ESC Heart Failure
Materias:	Heart failure HFrEF Iron deficiency Arrhythmia Ferric carboxymaltose FCM
Acceso en línea:	https://doi.org/10.1002/ehf2.14276
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!